AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders (Q43052731)
scientific article published on 7 May 2010
Language:
(P31) (Q13442814)
(P304) 46-57
(P407) (Q1860)
(P433) 1
(P478) 150
(P577) Friday, May 7, 2010
(P1433) (Q4970200)
(P1476) "AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders" (language: en)
(P2093) Mark A Dawson
Jayne E Curry
Kelly Barber
Philip A Beer
Brent Graham
John F Lyons
Caroline J Richardson
Mike A Scott
Tomoko Smyth
Matthew S Squires
Neil T Thompson
Anthony R Green
Nicola G Wallis
(P2860) (Q29618853)
(Q39851931)
other details
description scientific article published on 7 May 2010

External Links